A Multi-center Observational Study to Evaluate the Real-Life Effectiveness of Benepali® Following Transition From Enbrel® in Patients With Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA) - The BENEFIT Study
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms The BENEFIT Study
- Sponsors Biogen
- 10 Oct 2017 Status changed from not yet recruiting to recruiting.
- 12 Apr 2017 Planned initiation date changed from 1 Apr 2017 to 1 May 2017.
- 06 Apr 2017 New trial record